Dr Alison Goodwin: “Use of Vaccines” Presentation

This 76-page presentation was delivered to the Royal Commission of Inquiry (RCI) Phase 2 on 30 June 2025, by Dr Alison Goodwin. The document provides a detailed examination of New Zealand’s covid-19 vaccine programme across four critical areas:

Part 1: Background – Context and concerns that emerged during 2020, including early observations about risk assessment and treatment approaches.

Part 2: Vaccine Approval – Analysis of the rushed approval process, including Medsafe’s initial inability to recommend approval due to unclear benefit-risk balance, and the subsequent provisional consent despite safety and efficacy concerns.

Part 3: Vaccine Safety – Comprehensive review of New Zealand’s safety monitoring systems including:

• Post Vaccine Symptom Check (PVSC)
• Centre for Adverse Reactions Monitoring (CARM)
• Pathological mechanisms of potential harm
• Individual cases of affected New Zealanders
• ACC treatment injury processes
• Coronial service investigations

Part 4: Vaccine Mandates – Examination of the legal and ethical framework surrounding mandatory vaccination, including Bill of Rights Act considerations and the lack of evidence for transmission prevention.

Supporting Documentation

The presentation is accompanied by a comprehensive reference list containing 21 supporting documents, including:

• Original clinical trial data and evaluations
• Government correspondence and official assessments
• Safety monitoring reports and studies
• Legal documents and gazette notices
• Official information act responses

This material provides essential documentation for understanding the decision-making processes, safety monitoring systems, and regulatory frameworks that governed New Zealand’s covid-19 vaccine rollout.